Cite Filings / PRLD / 0001104659-26-046848

Feed Companies Filings Check

Sign in

SCHEDULE 13D/A

Beneficial Ownership Report

Prelude Therapeutics Inc Filed 2026-04-22 Acc 0001104659-26-046848

Documents 1

SCHEDULE 13D/A Beneficial Ownership Report , xslSCHEDULE_13D_X02/primary_doc.xml

Around this filing

2026-04-23 SCHEDULE 13D/A Beneficial Ownership Report
2026-04-23 4 Director bought 2,815,315 shares at $4.44 ($12,499,999)
2026-04-22 4 Options or other derivatives
2026-04-22 SCHEDULE 13D/A Beneficial Ownership Report
2026-04-21 8-K Material agreement · Other events
2026-04-21 424B5 Prospectus
2025-06-13 SCHEDULE 13D/A Beneficial Ownership Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…